180 related articles for article (PubMed ID: 8245477)
1. Increased gene expression of acetylcholine receptor and myogenic factors in passively transferred experimental autoimmune myasthenia gravis.
Asher O; Kues WA; Witzemann V; Tzartos SJ; Fuchs S; Souroujon MC
J Immunol; 1993 Dec; 151(11):6442-50. PubMed ID: 8245477
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis.
Losen M; Stassen MH; Martínez-Martínez P; Machiels BM; Duimel H; Frederik P; Veldman H; Wokke JH; Spaans F; Vincent A; De Baets MH
Brain; 2005 Oct; 128(Pt 10):2327-37. PubMed ID: 16150851
[TBL] [Abstract][Full Text] [Related]
3. Regulation of acetylcholine receptor alpha subunit variants in human myasthenia gravis. Quantification of steady-state levels of messenger RNA in muscle biopsy using the polymerase chain reaction.
Guyon T; Levasseur P; Truffault F; Cottin C; Gaud C; Berrih-Aknin S
J Clin Invest; 1994 Jul; 94(1):16-24. PubMed ID: 8040257
[TBL] [Abstract][Full Text] [Related]
4. Prevention of experimental autoimmune myasthenia gravis by a monoclonal antibody to a complementary peptide for the main immunogenic region of the acetylcholine receptors.
Araga S; Galin FS; Kishimoto M; Adachi A; Blalock JB
J Immunol; 1996 Jul; 157(1):386-92. PubMed ID: 8683141
[TBL] [Abstract][Full Text] [Related]
5. Passive transfer of experimental myasthenia gravis via antigenic modulation of acetylcholine receptor.
Loutrari H; Kokla A; Tzartos SJ
Eur J Immunol; 1992 Sep; 22(9):2449-52. PubMed ID: 1516631
[TBL] [Abstract][Full Text] [Related]
6. The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat.
Meinl E; Klinkert WE; Wekerle H
Am J Pathol; 1991 Nov; 139(5):995-1008. PubMed ID: 1951638
[TBL] [Abstract][Full Text] [Related]
7. Suppression of development of experimental autoimmune myasthenia gravis with isogeneic monoclonal anti-idiotopic antibody.
Agius MA; Richman DP
J Immunol; 1986 Oct; 137(7):2195-8. PubMed ID: 3489757
[TBL] [Abstract][Full Text] [Related]
8. Changes in the expression of mRNAs for myogenic factors and other muscle-specific proteins in experimental autoimmune myasthenia gravis.
Asher O; Fuchs S; Zuk D; Rapaport D; Buonanno A
FEBS Lett; 1992 Mar; 299(1):15-8. PubMed ID: 1312030
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of rapsyn in rat muscle increases acetylcholine receptor levels in chronic experimental autoimmune myasthenia gravis.
Martínez-Martínez P; Losen M; Duimel H; Frederik P; Spaans F; Molenaar P; Vincent A; De Baets MH
Am J Pathol; 2007 Feb; 170(2):644-57. PubMed ID: 17255332
[TBL] [Abstract][Full Text] [Related]
10. Regulation of acetylcholine receptor gene expression in human myasthenia gravis muscles. Evidences for a compensatory mechanism triggered by receptor loss.
Guyon T; Wakkach A; Poea S; Mouly V; Klingel-Schmitt I; Levasseur P; Beeson D; Asher O; Tzartos S; Berrih-Aknin S
J Clin Invest; 1998 Jul; 102(1):249-63. PubMed ID: 9649579
[TBL] [Abstract][Full Text] [Related]
11. Refractoriness to a second episode of experimental myasthenia gravis. Correlation with AChR concentration and morphologic appearance of the postsynaptic membrane.
Corey AL; Richman DP; Agius MA; Wollmann RL
J Immunol; 1987 May; 138(10):3269-75. PubMed ID: 3494763
[TBL] [Abstract][Full Text] [Related]
12. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH
J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the anti-acetylcholine receptor response and experimental autoimmune myasthenia gravis by recombinant fragments of the acetylcholine receptor.
Barchan D; Asher O; Tzartos SJ; Fuchs S; Souroujon MC
Eur J Immunol; 1998 Feb; 28(2):616-24. PubMed ID: 9521072
[TBL] [Abstract][Full Text] [Related]
14. Suppression of ongoing experimental myasthenia by oral treatment with an acetylcholine receptor recombinant fragment.
Im SH; Barchan D; Fuchs S; Souroujon MC
J Clin Invest; 1999 Dec; 104(12):1723-30. PubMed ID: 10606626
[TBL] [Abstract][Full Text] [Related]
15. Expression of acetylcholine receptor genes in human thymic epithelial cells: implications for myasthenia gravis.
Wakkach A; Guyon T; Bruand C; Tzartos S; Cohen-Kaminsky S; Berrih-Aknin S
J Immunol; 1996 Oct; 157(8):3752-60. PubMed ID: 8871679
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of hyperacute experimental autoimmune myasthenia gravis. Acetylcholine receptor/cholinergic site/receptor function/autoimmunity.
Mihovilovic M; Donnelly-Roberts D; Richman DP; Martinez-Carrion M
J Immunol; 1994 Jun; 152(12):5997-6002. PubMed ID: 8207224
[TBL] [Abstract][Full Text] [Related]
17. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
Atassi MZ; Oshima M; Deitiker P
Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
[TBL] [Abstract][Full Text] [Related]
18. Increased levels of acetylcholine receptor alpha-subunit mRNA in experimental autoimmune myasthenia gravis.
Asher O; Neumann D; Fuchs S
FEBS Lett; 1988 Jun; 233(2):277-81. PubMed ID: 3260196
[TBL] [Abstract][Full Text] [Related]
19. Resistance to experimental autoimmune myasthenia gravis in genetically inbred rats. Association with decreased amounts of in situ acetylcholine receptor-antibody complexes.
Biesecker G; Koffler D
J Immunol; 1988 May; 140(10):3406-10. PubMed ID: 3258882
[TBL] [Abstract][Full Text] [Related]
20. Lewis rats given antibodies against denatured acetylcholine receptor become resistant to induction of experimental autoimmune myasthenia gravis.
Krolick KA; Yeh TM; Edlund SA
Cell Immunol; 1996 Aug; 172(1):10-20. PubMed ID: 8806801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
